CORT - Company ID 0001088856
The table below shows CORCEPT THERAPEUTICS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $98.72M | $111.04M | $108.74M | $125.14M | $102.75M | $89.82M |
| Short-term investments | $271.98M | $197.16M | $229.45M | $296.55M | $239.48M | $232.94M |
| Receivables | $111.06M | $76.92M | $39.07M | $69.63M | $64.57M | $61.82M |
| Inventory | $11.91M | $13.19M | $12.89M | $12.35M | $12.28M | $14.37M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $533.87M |
| $439.68M |
| $426.03M |
| $541.13M |
| $443.11M |
| $438.50M |
| Property, plant & equipment | $4.94M | $5.13M | $3.17M | $2.09M | $2.35M | $2.54M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.03B | $888.70M | $814.88M | $823.61M | $801.72M | $846.46M |
| Accounts payable | $21.92M | $14.91M | $33.31M | $34.45M | $23.52M | $27.95M |
| Total current liabilities | $177.68M | $153.80M | $149.19M | $172.26M | $144.66M | $143.07M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $200.29M | $182.93M | $176.89M | $191.71M | $165.93M | $163.17M |
| Retained earnings | $781.39M | $654.61M | $611.63M | $619.10M | $599.43M | $564.28M |
| Total equity | $833.74M | $705.78M | $637.99M | $631.90M | $635.79M | $683.28M |